183 related articles for article (PubMed ID: 32221538)
21. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
22. Chemokine CXC Ligand 13 in Cerebrospinal Fluid Can Be Used as an Early Diagnostic Biomarker for Lyme Neuroborreliosis: A Meta-Analysis.
Yang J; Han X; Liu A; Bao F; Peng Y; Tao L; Ma M; Bai R; Dai X
J Interferon Cytokine Res; 2017 Oct; 37(10):433-439. PubMed ID: 28972436
[TBL] [Abstract][Full Text] [Related]
23. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.
van Burgel ND; Bakels F; Kroes AC; van Dam AP
J Clin Microbiol; 2011 May; 49(5):2027-30. PubMed ID: 21367992
[TBL] [Abstract][Full Text] [Related]
24. Positive intrathecal anti-Borrelia antibody synthesis: what are the implications for clinical practice? Clinical features and outcomes of 138 patients in a French multicenter cohort study.
Naudion P; Raffetin A; Zayet S; Klopfenstein T; Baux E; Martinot M; Piroth L; Caumes E; Chirouze C; Bouiller K
Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):441-452. PubMed ID: 36806057
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity and specificity of cerebrospinal fluid CXCL13 for diagnosing Lyme neuroborreliosis - a study on 1410 patients and review of the literature.
Lintner H; Hochgatterer-Rechberger P; Pischinger B; Seier J; Vollmann P; Haushofer A; Rittner H; Sommer C; Topakian R
J Neurol Sci; 2020 Jul; 414():116843. PubMed ID: 32344220
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid cytokines in Lyme neuroborreliosis.
Pietikäinen A; Maksimow M; Kauko T; Hurme S; Salmi M; Hytönen J
J Neuroinflammation; 2016 Oct; 13(1):273. PubMed ID: 27756335
[TBL] [Abstract][Full Text] [Related]
27. CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland Å
J Neurol; 2008 May; 255(5):782. PubMed ID: 27517589
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.
Rupprecht TA; Manz KM; Fingerle V; Lechner C; Klein M; Pfirrmann M; Koedel U
Clin Microbiol Infect; 2018 Dec; 24(12):1234-1240. PubMed ID: 29674128
[TBL] [Abstract][Full Text] [Related]
29. Point-of-care testing for CXCL13 in Lyme neuroborreliosis.
Pietikäinen A; Oksi J; Hytönen J
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125
[TBL] [Abstract][Full Text] [Related]
30. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum.
Zomer TP; Bruinsma R; van Samkar A; Vermeeren YM; Wieberdink RG; van Kooten B; van Bemmel T
Eur J Neurol; 2023 Mar; 30(3):741-744. PubMed ID: 36371644
[TBL] [Abstract][Full Text] [Related]
31. Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections.
Pícha D; Moravcová L; Smíšková D
J Neurol Sci; 2016 Sep; 368():214-20. PubMed ID: 27538636
[TBL] [Abstract][Full Text] [Related]
32. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy.
Eckman EA; Pacheco-Quinto J; Herdt AR; Halperin JJ
Clin Infect Dis; 2018 Jun; 67(1):80-88. PubMed ID: 29340592
[TBL] [Abstract][Full Text] [Related]
33. Peripheral neuropathy due to neuroborreliosis: Insensitivity for CXCL13 as early diagnostic marker.
Gubanova K; Lang J; Latzko J; Novotna B; Perneczky J; Pingitzer S; Purer P; Wuchty B; Waiß C; Sellner J
Int J Infect Dis; 2021 Apr; 105():460-462. PubMed ID: 33684563
[TBL] [Abstract][Full Text] [Related]
34. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
[TBL] [Abstract][Full Text] [Related]
35. The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.
Dersch R; Hottenrott T; Senel M; Lehmensiek V; Tumani H; Rauer S; Stich O
Fluids Barriers CNS; 2015 May; 12():12. PubMed ID: 25975424
[TBL] [Abstract][Full Text] [Related]
36. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays.
Henningsson AJ; Christiansson M; Tjernberg I; Löfgren S; Matussek A
Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):797-803. PubMed ID: 24263552
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis.
Djukic M; Schmidt-Samoa C; Lange P; Spreer A; Neubieser K; Eiffert H; Nau R; Schmidt H
J Neurol; 2012 Apr; 259(4):630-6. PubMed ID: 21898139
[TBL] [Abstract][Full Text] [Related]
38. Direct Molecular Detection and Genotyping of Borrelia burgdorferi Sensu Lato in Cerebrospinal Fluid of Children with Lyme Neuroborreliosis.
Barstad B; Quarsten H; Tveitnes D; Noraas S; Ask IS; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29467195
[TBL] [Abstract][Full Text] [Related]
39. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
